Relatively insufficient-supply amyloid beta aggregation inhibitors for improving detoxification effects

Provided herein is a method of treating or preventing protein misfolding and deposition diseases in a subject by administering to the subject a low dose of Compound (1). Also provided herein is a method of reversing or preventing the toxic effect of the misfolded and aggregated protein amyloid beta...

Full description

Saved in:
Bibliographic Details
Main Authors RAMS GERRIT, RATH HEMANT KUMAR
Format Patent
LanguageChinese
English
Published 07.01.2025
Subjects
Online AccessGet full text

Cover

More Information
Summary:Provided herein is a method of treating or preventing protein misfolding and deposition diseases in a subject by administering to the subject a low dose of Compound (1). Also provided herein is a method of reversing or preventing the toxic effect of the misfolded and aggregated protein amyloid beta by using a relatively insufficient supply (reverse stoichiometric) compound (1) to achieve a stronger detoxification effect. The invention further provides the dosage and the application mode of the composition. 本文提供了一种通过向受试者施用低剂量的化合物(1)来治疗或预防所述受试者中蛋白质错折叠和沉积病的方法。本文还提供了一种通过使用相对供应不足(反向化学计量比)的化合物(1)来实现更强的解毒效果,从而逆转或预防错折叠和聚集的蛋白质淀粉样蛋白β的毒性作用的方法。还提供了其剂量和施用方式。
Bibliography:Application Number: CN20238043085